Subfulminant hepatitis B after infliximab in Crohn&rsquo;s disease: Need for HBV-screening?

doi:10.3748/wjg.v12.i6.974

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (1938)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series.

Item

Count

PDF

396

HTML

1429

Figures (1-1)

109

Sum=1934

Feb 14, 2006 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (110)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Feb 14, 2006; 12(6): 974-976
Published online Feb 14, 2006. doi: 10.3748/wjg.v12.i6.974

Subfulminant hepatitis B after infliximab in Crohn’s disease: Need for HBV-screening?

Gunda Millonig, Michaela Kern, Othmar Ludwiczek, Karin Nachbaur, Wolfgang Vogel

Gunda Millonig, Michaela Kern, Othmar Ludwiczek, Karin Nachbaur, Wolfgang Vogel, Department of Gastroenterology and Hepatology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria

Supported by the “Verein zur Förderung der Wissenschaft in Gastroenterologie und Hepatologie”

Correspondence to: Gunda Millonig, MD, Department of Gastroenterology and Hepatology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. gunda.millonig@uibk.ac.at

Telephone: +43-512-504-23401 Fax: +43-512-504-24052

Received: April 30, 2005
Revised: May 10, 2005
Accepted: June 9, 2005
Published online: February 14, 2006

Core Tip